GoRockyPh
Regular price₱1,599.00 PHP
Sale price
Unit price/perSaleSold outPacks 4 pills (GET 4 FREE)Variant sold out or unavailable8 pills (GET 8 FREE)12 pillsProduct variants 4 pills (GET 4 FREE) - ₱1,599.008 pills (GET 8 FREE) - ₱2,999.0012 pills - ₱4,199.00Couldn't load pickup availability
RefreshTadalafil 20mg
Experience long-lasting performance with Tadalafil 20mg. Known for its extended effectiveness up to 36 hours, it allows for greater spontaneity and confidence in your intimate moments.
Product Details:
Benefits:
How It Works:
Experience long-lasting confidence with GoRocky's Tadalafil 20mg. Trust in our extended-effect solution to enhance your performance and improve your intimate moments.
Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share Share ShareShare Share Share Share Share Share Share Share shareExperience long-lasting performance with GoRock's Tadalafil 20mg.
Explore the possibilities of Tadalafil 20mg in your portfolio. Get to experience the medication in a variety of forms, including tablets, oral suspension, and intravenous solutions.”
Read this answer on page https://www.rockawaysph.com/tadalafil-pill-formula/page/4087 "Tadalafil 20mg"Tadalafil is approved for the treatment of:
Tadalafil 20mg tablets are taken by mouth. The dosage is based on your age, response to treatment, and overall health.
Medicinal drugs should not be used in pregnancy.
1. KD. Tripathi. Androgens and Drugs for Erectile Dysfunction. Essentials of medical pharmacology. Seventh edition. 2013. Page-304.
2. Adam M Henrie, James J Nawarskas, and Joe R Anderson. Clinical utility of tadalafil in the treatment of pulmonary arterial hypertension: an evidence-based review. NIH. National Library of Medicine. National Center for Biotechnology Information. PMC. PubMed Central. November 2015. [Accessed on November 08th, 2023]https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636095/
3. Accord Healthcare Limited. Electronic Medicines Compendium (EMC). [Revised in October 2021] [Accessed on November 08th, 2023]https://www.medicines.org.uk/emc/files/pil.8637.pdf
4. Leeford Healthcare Private Ltd. Bigfun-36.https://www.leeford.in/product/556/bigfun-36
5. Central Drugs Standard Control Organization. Tadalafil tablet 20 mg (Additional Indication). [Revised in November 2009]. Tadalafil 10mg/20mg Tablets. [Revised in September 2003] [Accessed on November 08th, 2023]https://cdscoonline.gov.in/CDSCO/Drugs
Amanitanchez Machado Janssen Co. Virologist Caioban Xuang Youniao D. Magnutics B. N Engl J Med. 2018;375:53-53.. Aaliboruy J. Statins. [Accessed on November 08th, 2023] Aaliboruy. [Accessed on November 08th, 2023].innamon.com. [Accessed on November 08th, 2023]innamon.com.
topiramate. [Accessed on November 08th, 2023]topiramate.
tamoxifen citrate. [Accessed on November 08th, 2023]tamoxifen.
topicalcarberen.
Emily-Anne Luddenall A. Eli Lilly & Co. S.r.l. [Accessed on November 08th, 2023]S. L. Upadhyay Janssen Pharm.GoRockyPh
Regular price₱1,599.00 PHP
Sale price
Unit price/perSaleSold outPacks 4 pills (GET 4 FREE)Variant sold out or unavailable8 pills (GET 8 FREE)12 pillsProduct variants 4 pills (GET 4 FREE) - ₱1,599.008 pills (GET 8 FREE) - ₱2,999.0012 pills - ₱4,199.00Couldn't load pickup availability
RefreshTadalafil 20mg
Experience long-lasting performance with Tadalafil 20mg. Known for its extended effectiveness up to 36 hours, it allows for greater spontaneity and confidence in your intimate moments.
Product Details:
Benefits:
How It Works:
Experience long-lasting confidence with GoRocky's Tadalafil 20mg. Trust in our extended-effect solution to enhance your performance and improve your intimate moments.
Share Share Share Share Share Share Share Share Share Share Share Share1GoRockyPh 20mg
Experience the confidence and intimacy Tadalafil has to offer. This powerful medication offers over 30 hours of effectiveness in treating erectile dysfunction. It's designed to Be...
Tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor, has emerged as a potential therapeutic approach for the treatment of various pulmonary arterial hypertension (PAH) diseases [
]. The pharmacological mechanisms of tadalafil are distinct from those of phosphodiesterase type 5 inhibitors (PDE5 inhibitors), which are known for their selective and reversible inhibition of PDE5, a process critical for cell migration and tissue relaxation in vessels and for their enhanced therapeutic efficacy [
Tadalafil has demonstrated excellent efficacy in PAH patients with mild to moderate risk factors for PAH such as high blood pressure and high mortality [
The therapeutic benefits of tadalafil have been demonstrated in animal and human studies, where it improved exercise capacity, increased survival rates in the pulmonary artery, and reduced pulmonary vascular resistance [
Furthermore, studies on the effect of tadalafil on pulmonary arterial hypertension in animal models have been conducted [
Tadalafil has also been demonstrated to reduce exercise-induced pulmonary edema, which is associated with the release of vasodilators, including angiotensin II, norepinephrine, and triprolidine, from vascular smooth muscle cells and their subsequent degradation in vascular smooth muscle [
Tadalafil has also been demonstrated to reduce cardiovascular mortality in patients with PAH. In PAH, the efficacy of tadalafil in reducing exercise-induced pulmonary edema was demonstrated in animal models in various experimental models, including a mouse model with systemic hypertension and an ischemic heart disease [
,
Furthermore, tadalafil has demonstrated potential as a novel therapeutic agent for patients with PAH with pulmonary arterial hypertension [
Tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor, has been demonstrated to be selective for PDE5, which is involved in the smooth muscle relaxation of vascular smooth muscle cells and vascular tone. The inhibition of PDE5 is initiated by the inhibition of the enzyme phosphodiesterase type 5 (PDE5), which is primarily located within the smooth muscle cells of vascular smooth muscle [
PDE5 is responsible for the degradation of cyclic guanosine monophosphate (cGMP), the primary mediator of smooth muscle relaxation. cGMP is a chemical that relaxes vascular smooth muscle cells and is responsible for the release of vasodilators and other vasodilators, including angiotensin II, norepinephrine, and triprolidine, from vascular smooth muscle cells and their subsequent degradation in vascular smooth muscle [
PDE5 is a type of cyclic guanosine monophosphate (cGMP), which works by binding to cGMP and subsequently inhibiting the PDE action of PDE5. cGMP is an essential molecule for the relaxation and contraction of smooth muscle cells, and it is also the molecule that mediates the phosphorylation of cyclic nucleotide, a substance that regulates the level of cGMP in the smooth muscle cell, thereby mediating cell processes that control the contraction of the vascular smooth muscle cell [
PDE5 is responsible for the relaxation of vascular smooth muscle and the increased levels of cGMP in the smooth muscle cells of the pulmonary arterial artery. cGMP is a molecule that is found in the endothelium of the pulmonary arteries and is associated with smooth muscle cell proliferation, migration, and cGMP degradation [
Inhibition of PDE5 by tadalafil reduces cGMP levels in pulmonary arteries and decreases cGMP in pulmonary arterial hypertension [
Tadalafil has also demonstrated potential as a novel therapeutic agent for patients with PAH with pulmonary arterial hypertension [
Tadalafil is currently approved for the treatment of pulmonary arterial hypertension, the first-line treatment for PAH in patients with risk factors for pulmonary arterial hypertension, including high blood pressure and hypertension. The approved indications for tadalafil in PAH are as follows: Pulmonary hypertension in adults with pulmonary arterial hypertension, as well as pulmonary arterial hypertension in children and adolescents, including the elderly [
], which is a significant burden for both healthcare providers and patients [
1. KD. Tripathi. Androgens and Drugs for Erectile Dysfunction. Essentials of medical pharmacology. Seventh edition. 2013. Page-304.
2. Adam M Henrie, James J Nawarskas, and Joe R Anderson. Clinical utility of tadalafil in the treatment of pulmonary arterial hypertension: an evidence-based review. NIH. National Library of Medicine. National Center for Biotechnology Information. PMC. PubMed Central. November 2015. [Accessed on November 08th, 2023]https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636095/
3. Accord Healthcare Limited. Electronic Medicines Compendium (EMC). [Revised in October 2021] [Accessed on November 08th, 2023]https://www.medicines.org.uk/emc/files/pil.8637.pdf
4. Leeford Healthcare Private Ltd. Bigfun-36.https://www.leeford.in/product/556/bigfun-36
5. Central Drugs Standard Control Organization. Tadalafil tablet 20 mg (Additional Indication). [Revised in November 2009]. Tadalafil 10mg/20mg Tablets. [Revised in September 2003] [Accessed on November 08th, 2023]https://cdscoonline.gov.in/CDSCO/Drugs
PER PRODUCTIVE Reuters On November 08, 2023, 10:00 a.p.m. PCCO, an international standards organization that regulates research and scientific information, published the results of a 14-month review of the data. According to PCCO, 15 studies per month have been published with PCCO-approved EMC-approved safety and T20/40 EMC-approved T20/40 EMC-approved safety and T20/40 EMC-approved safety and T20/40 EMC-approved safety and T20/40 EMC-approved safety and EMC-approved T20/40 EMC-approved T20/40 EMC-approved T20/40 EMC-approved T20/40 EMC-approved T20/40 EMC-approved T20/40 EMC-approved T20/40 EMC-approved T20/40 EMC-approved [ON-HSE]was the primary outcome. Secondary outcomes were the mean age and mean time to first EMC-approved safety or safety EMC-approved T20/40 EMC-approved safety or EMC-approved EMC-approved EMC-approved EMC-approved safety or safety EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved safety or EMC-approved [SEP] or other information.
was analyzed using the Revieworts ANOVA and quadroxial RevMan.